Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (3476)
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
440
Price
$533.28
Total Value
$234.64K
Shares Held After
326,522
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
520
Price
$532.14
Total Value
$276.71K
Shares Held After
326,962
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,924
Price
$530.14
Total Value
$1.02M
Shares Held After
327,482
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
3,057
Price
$529.46
Total Value
$1.62M
Shares Held After
329,406
% of Holdings
0.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,400
Price
$528.42
Total Value
$739.78K
Shares Held After
332,463
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$527.31
Total Value
$42.19K
Shares Held After
333,863
% of Holdings
0.0%
Monte Rosa Therapeutics, Inc. (GLUE)
Warmuth Markus — Director
Shares
9,500
Price
$23.18
Total Value
$220.22K
Shares Held After
585,038
% of Holdings
1.6%
Greenland Mines Ltd (GRML)
LeBlanc Jeff — Chief Financial Officer
Shares
1,400,000
Price
$0.18
Total Value
$245.28K
Shares Held After
4,820,342
% of Holdings
29.0%
InMed Pharmaceuticals Inc. (INM)
Vivo Opportunity, LLC — 10% Owner
Shares
2
Price
$1.55
Total Value
$3.10
Shares Held After
75,019
% of Holdings
0.0%
InMed Pharmaceuticals Inc. (INM)
Vivo Opportunity, LLC — 10% Owner
Shares
19
Price
$1.55
Total Value
$29.45
Shares Held After
743,057
% of Holdings
0.0%
Boundless Bio, Inc. (BOLD)
TANG KEVIN — 10% Owner
Shares
18,491
Price
$2.44
Total Value
$45.12K
Shares Held After
2,854,072
% of Holdings
0.6%
ADIAL PHARMACEUTICALS, INC. (ADIL)
Coastlands Capital LP — 10% Owner
Shares
1,233
Price
$2.75
Total Value
$3.39K
Shares Held After
388,308
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
80
Price
$536.85
Total Value
$42.95K
Shares Held After
45,172
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
1,519
Price
$534.99
Total Value
$812.65K
Shares Held After
45,252
% of Holdings
3.2%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
1,041
Price
$535.88
Total Value
$557.85K
Shares Held After
46,771
% of Holdings
2.2%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
3,279
Price
$534.21
Total Value
$1.75M
Shares Held After
47,812
% of Holdings
6.4%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
800
Price
$532.94
Total Value
$426.35K
Shares Held After
51,091
% of Holdings
1.5%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
861
Price
$531.97
Total Value
$458.03K
Shares Held After
51,891
% of Holdings
1.6%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
120
Price
$529.81
Total Value
$63.58K
Shares Held After
52,752
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
600
Price
$527.60
Total Value
$316.56K
Shares Held After
52,872
% of Holdings
1.1%
FORUM MARKETS Inc (FRMM)
Lomashuk Konstantin — 10% Owner
Shares
2,562
Price
$6.30
Total Value
$16.14K
Shares Held After
1,476,638
% of Holdings
0.2%
MapLight Therapeutics, Inc. (MLPT)
Kreitzer Anatol — Chief Discovery Officer
Shares
4,510
Price
$36.94
Total Value
$166.60K
Shares Held After
201,135
% of Holdings
2.2%
MapLight Therapeutics, Inc. (MLPT)
Kreitzer Anatol — Chief Discovery Officer
Shares
5,545
Price
$36.13
Total Value
$200.34K
Shares Held After
205,645
% of Holdings
2.6%
MapLight Therapeutics, Inc. (MLPT)
GILLIS JONATHAN — CAO and Interim CFO
Shares
4,699
Price
$36.94
Total Value
$173.58K
Shares Held After
171,164
% of Holdings
2.7%
MapLight Therapeutics, Inc. (MLPT)
GILLIS JONATHAN — CAO and Interim CFO
Shares
5,356
Price
$36.13
Total Value
$193.51K
Shares Held After
175,863
% of Holdings
3.0%
MapLight Therapeutics, Inc. (MLPT)
Kroeger Christopher A. — Director
Shares
90
Price
$37.54
Total Value
$3.38K
Shares Held After
1,332,316
% of Holdings
0.0%
MapLight Therapeutics, Inc. (MLPT)
Kroeger Christopher A. — Director
Shares
42,738
Price
$36.99
Total Value
$1.58M
Shares Held After
1,332,406
% of Holdings
3.1%
MapLight Therapeutics, Inc. (MLPT)
Kroeger Christopher A. — Director
Shares
18,950
Price
$36.00
Total Value
$682.20K
Shares Held After
1,375,144
% of Holdings
1.4%
MapLight Therapeutics, Inc. (MLPT)
Lillie James Woodruff — Chief Scientific Officer
Shares
12
Price
$37.54
Total Value
$450.48
Shares Held After
235,086
% of Holdings
0.0%
MapLight Therapeutics, Inc. (MLPT)
Lillie James Woodruff — Chief Scientific Officer
Shares
5,393
Price
$36.99
Total Value
$199.49K
Shares Held After
235,098
% of Holdings
2.2%
MapLight Therapeutics, Inc. (MLPT)
Lillie James Woodruff — Chief Scientific Officer
Shares
2,238
Price
$36.00
Total Value
$80.57K
Shares Held After
240,491
% of Holdings
0.9%
MapLight Therapeutics, Inc. (MLPT)
Foff Erin Pennock — Chief Medical Officer
Shares
18
Price
$37.54
Total Value
$675.72
Shares Held After
317,604
% of Holdings
0.0%
MapLight Therapeutics, Inc. (MLPT)
Foff Erin Pennock — Chief Medical Officer
Shares
8,972
Price
$36.99
Total Value
$331.87K
Shares Held After
317,622
% of Holdings
2.7%
MapLight Therapeutics, Inc. (MLPT)
Foff Erin Pennock — Chief Medical Officer
Shares
4,465
Price
$36.00
Total Value
$160.74K
Shares Held After
326,594
% of Holdings
1.3%
MapLight Therapeutics, Inc. (MLPT)
Foff Erin Pennock — Chief Medical Officer
Shares
7,845
Price
$37.04
Total Value
$290.58K
Shares Held After
331,059
% of Holdings
2.3%
MapLight Therapeutics, Inc. (MLPT)
Foff Erin Pennock — Chief Medical Officer
Shares
7,155
Price
$36.16
Total Value
$258.72K
Shares Held After
338,904
% of Holdings
2.1%
MapLight Therapeutics, Inc. (MLPT)
Hanson Kristopher — General Counsel
Shares
10
Price
$37.54
Total Value
$375.40
Shares Held After
155,071
% of Holdings
0.0%
MapLight Therapeutics, Inc. (MLPT)
Hanson Kristopher — General Counsel
Shares
5,103
Price
$36.99
Total Value
$188.76K
Shares Held After
155,081
% of Holdings
3.2%
MapLight Therapeutics, Inc. (MLPT)
Hanson Kristopher — General Counsel
Shares
2,147
Price
$36.00
Total Value
$77.29K
Shares Held After
160,184
% of Holdings
1.3%
Adaptive Biotechnologies Corp (ADPT)
LO FRANCIS — Chief People Officer
Shares
105,762
Price
$22.59
Total Value
$2.39M
Shares Held After
230,713
% of Holdings
31.4%
InMed Pharmaceuticals Inc. (INM)
ADAR1 Capital Management, LLC — 10% Owner
Shares
1,000
Price
$1.55
Total Value
$1.55K
Shares Held After
801,000
% of Holdings
0.1%
Septerna, Inc. (SEPN)
Bhatt Elizabeth — President and COO
Shares
4,000
Price
$33.99
Total Value
$135.97K
Shares Held After
174,209
% of Holdings
2.2%
CORCEPT THERAPEUTICS INC (CORT)
WILSON JAMES N — Director
Shares
1,978
Price
$89.49
Total Value
$177.01K
Shares Held After
1,084,543
% of Holdings
0.2%
CORCEPT THERAPEUTICS INC (CORT)
WILSON JAMES N — Director
Shares
2,974
Price
$88.81
Total Value
$264.12K
Shares Held After
1,086,521
% of Holdings
0.3%
CORCEPT THERAPEUTICS INC (CORT)
WILSON JAMES N — Director
Shares
3,969
Price
$87.74
Total Value
$348.22K
Shares Held After
1,089,495
% of Holdings
0.4%
CORCEPT THERAPEUTICS INC (CORT)
WILSON JAMES N — Director
Shares
1,079
Price
$86.78
Total Value
$93.63K
Shares Held After
1,093,464
% of Holdings
0.1%
CORCEPT THERAPEUTICS INC (CORT)
Mokari Atabak — Chief Financial Officer
Shares
101
Price
$89.43
Total Value
$9.03K
Shares Held After
16,130
% of Holdings
0.6%
CORCEPT THERAPEUTICS INC (CORT)
Mokari Atabak — Chief Financial Officer
Shares
3,520
Price
$88.30
Total Value
$310.82K
Shares Held After
16,231
% of Holdings
17.8%
CORCEPT THERAPEUTICS INC (CORT)
Mokari Atabak — Chief Financial Officer
Shares
28,460
Price
$87.89
Total Value
$2.50M
Shares Held After
19,751
% of Holdings
59.0%
CORCEPT THERAPEUTICS INC (CORT)
Mokari Atabak — Chief Financial Officer
Shares
7,919
Price
$86.78
Total Value
$687.18K
Shares Held After
48,211
% of Holdings
14.1%
Showing 301–350 of 3476 transactions (page 7 of 70)